Methods and systems for cryptographically secured outputs from telemedicine sessions
A system for cryptographically secured outputs from telemedicine sessions includes a computing device at a first location, the computing device configured to initiate a secure communication interface between the computing device and a client device associated with a human subject and at a second location, receive, from at least a remote sensor at the second location, a plurality of current biological data associated with the human subject, input, using the secure communication interface, an identifier of a biochemical element, determine, as a function of the plurality of current biological data, a tolerability of the biochemical element, and generate a digitally signed authorization datum as a function of the determination.
1 . A system for cryptographically secured outputs from telemedicine sessions, the system comprising a computing device, the computing device configured to:
receive a plurality of current biological data associated with a human subject from a client device;
obtain a plurality of biochemical elements;
determine a biochemical element of the plurality of biochemical elements as a function of the plurality of current biological data using a pharmaceutical classifier which comprises:
receiving a training data set correlating the plurality of current biological data to a plurality of biochemical element data;
training, iteratively, the pharmaceutical classifier using the training data set, wherein training the pharmaceutical classifier includes retraining the pharmaceutical classifier with feedback from previous iterations of the pharmaceutical classifier; and
determining the plurality of biochemical elements as a function of the trained pharmaceutical classifier;
generate a digitally signed authorization datum as a function of the determination;
generate at least a biometric identification signature of the human subject, wherein generating further comprises:
receiving subject signature training data, including a plurality of category descriptors and correlated biological data entries;
training a biometric signature model as a function of the subject signature training data and a machine-learning process; and
generating the biometric identification signature as a function of the biometric signature model; and
authenticate the plurality of current biological data as a function of a degree of similarity between the plurality of current biological data and the at least a biometric identification signature.
2 . The system of claim 1 , wherein the plurality of current biological data comprises cardiovascular data.
3 . The system of claim 1 , wherein the client device comprises at least a remote sensor.
4 . The system of claim 1 , wherein the computing device is further configured to identify one or more conditions of the human subject as a function of the plurality of current biological data.
5 . The system of claim 4 , wherein the one or more conditions comprises a chronic disease.
6 . The system of claim 1 , wherein the computing device is further configured to initiate a secure communication interface between the computing device at a first location and the client device associated with the human subject and at a second location.
7 . The system of claim 1 , wherein the computing device is further configured to determine a tolerability of the biochemical element of the plurality of biochemical elements as a function of the plurality of current biological data.
8 . The system of claim 1 , wherein the digitally signed authorization datum includes a timestamp indicating a time of initiation.
9 . The system of claim 1 , wherein the computing device is further configured to:
generate a transfer datum as a function of determination of the biochemical element; and
transmit the transfer datum to a third party.
10 . The system of claim 1 , wherein the computing device is further configured to:
receive a treatment response; and
update the biochemical element as a function of the treatment response.
11 . A method of cryptographically secured outputs from telemedicine sessions, the method comprising:
receiving, using a computing device, a plurality of current biological data associated with a human subject from a client device;
obtaining, using the computing device, a plurality of biochemical elements;
determining, using the computing device, a biochemical element of the plurality of biochemical elements as a function of the plurality of current biological data using a pharmaceutical classifier which comprises:
receiving a training data set correlating the plurality of current biological data to a plurality of biochemical element data;
training, iteratively, the pharmaceutical classifier using the training data set, wherein training the pharmaceutical classifier includes retraining the pharmaceutical classifier with feedback from previous iterations of the pharmaceutical classifier; and
determining the plurality of biochemical elements as a function of the trained pharmaceutical classifier;
generating, using the computing device, a digitally signed authorization datum as a function of the determination;
generating, using the computing device, at least a biometric identification signature of the human subject, wherein generating further comprises:
receiving subject signature training data, including a plurality of category descriptors and correlated biological data entries;
training a biometric signature model as a function of the subject signature training data and a machine-learning process; and
generating the biometric identification signature as a function of the biometric signature model; and
authenticating, using the computing device, the plurality of current biological data as a function of a degree of similarity between the plurality of current biological data and the at least a biometric identification signature.
12 . The method of claim 11 , wherein the plurality of current biological data comprises cardiovascular data.
13 . The method of claim 11 , wherein the client device comprises at least a remote sensor.
14 . The method of claim 11 , further comprising:
identifying, using the computing device, one or more conditions of the human subject as a function of the plurality of current biological data.
15 . The method of claim 14 , wherein the one or more conditions comprises a chronic disease.
16 . The method of claim 11 , further comprising:
initiating, using the computing device, a secure communication interface between the computing device at a first location and the client device associated with the human subject and at a second location.
17 . The method of claim 11 , further comprising:
determining, using the computing device, a tolerability of the biochemical element of the plurality of biochemical elements as a function of the plurality of current biological data.
18 . The method of claim 11 , wherein the digitally signed authorization datum includes a timestamp indicating a time of initiation.
19 . The method of claim 11 , further comprising:
generating, using the computing device, a transfer datum as a function of determination of the biochemical element; and
transmitting, using the computing device, the transfer datum to a third party.
20 . The method of claim 11 , further comprising:
receiving, using the computing device, a treatment response; and
updating, using the computing device, the biochemical element as a function of the treatment response.